These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32021295)

  • 1. Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells.
    Zhu Q; Shen Y; Chen X; He J; Liu J; Zu X
    Onco Targets Ther; 2020; 13():525-540. PubMed ID: 32021295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling mechanism(s) of epithelial-mesenchymal transition and cancer stem cells in tumour therapeutic resistance.
    Cai Z; Cao Y; Luo Y; Hu H; Ling H
    Clin Chim Acta; 2018 Aug; 483():156-163. PubMed ID: 29709449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.
    Horne GA; Copland M
    Expert Opin Drug Discov; 2017 May; 12(5):465-474. PubMed ID: 28277836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of breast cancer stem cell features.
    Czerwinska P; Kaminska B
    Contemp Oncol (Pozn); 2015; 19(1A):A7-A15. PubMed ID: 25691826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells.
    Li H; Feng Z; He ML
    Theranostics; 2020; 10(16):7053-7069. PubMed ID: 32641978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
    Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
    Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cells and Treatment of Cancer: An Update and Future Perspectives.
    Khan M; Naeem M; Chaudary SA; Ahmed A; Ahmed A
    Curr Stem Cell Res Ther; 2024; 19(10):1312-1320. PubMed ID: 37818567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers.
    Mudra SE; Sadhukhan P; Ugurlu MT; Alam S; Hoque MO
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
    Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine signalling in embryonic stem cells.
    Kristensen DM; Kalisz M; Nielsen JH
    APMIS; 2005; 113(11-12):756-72. PubMed ID: 16480448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural compounds as a potential modifier of stem cells renewal: Comparative analysis.
    Mishra A; Pathak Y; Mishra SK; Prakash H; Tripathi V
    Eur J Pharmacol; 2023 Jan; 938():175412. PubMed ID: 36427534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy.
    Borah A; Raveendran S; Rochani A; Maekawa T; Kumar DS
    Oncogenesis; 2015 Nov; 4(11):e177. PubMed ID: 26619402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
    Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
    Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
    Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
    Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.